COVID-19 ‘Vaccine’ Deaths Soar in Europe. Mass Funeral

New Post Public Reply Private Reply Replies (0) Message Board
Rusty
259
COVID-19 ‘Vaccine’ Deaths Soar in Europe. Mass Funeral Protest for Children Held in Switzerland
February 15, 2022

f882337961f9d533f4a0375886557eb3.png

The European database of suspected drug reactions, EudraVigilance, is now reporting 38,983 fatalities, and 3,530,362 injuries following injections of four experimental COVID-19 shots including Moderna, Pfizer, AstraZeneca and Janssen (Johnson & Johnson). Almost half of the recorded injuries are serious. On January 29, 2021 a mass funeral protest for children who have died after receiving a Pfizer vaccine was held in Geneva, Switzerland.

The European (EEA and non-EEA countries) database of suspected drug reaction reports is EudraVigilance, verified by the European Medicines Agency (EMA), and they are now reporting 38,983 fatalities, and 3,530,362 injuries following injections of four experimental COVID-19 shots:

COVID-19 MRNA VACCINE MODERNA (CX-024414)
COVID-19 MRNA VACCINE PFIZER-BIONTECH
COVID-19 VACCINE ASTRAZENECA (CHADOX1 NCOV-19)
COVID-19 VACCINE JANSSEN (AD26.COV2.S)

From the total of injuries recorded, almost half of them (1,672,872 ) are serious injuries.

“Seriousness provides information on the suspected undesirable effect; it can be classified as ‘serious’ if it corresponds to a medical occurrence that results in death, is life-threatening, requires inpatient hospitalisation, results in another medically important condition, or prolongation of existing hospitalisation, results in persistent or significant disability or incapacity, or is a congenital anomaly/birth defect.”

A Health Impact News subscriber in Europe ran the reports for each of the four COVID-19 shots we are including here. It is a lot of work to tabulate each reaction with injuries and fatalities, since there is no place on the EudraVigilance system we have found that tabulates all the results.

Since we have started publishing this, others from Europe have also calculated the numbers and confirmed the totals.*

Here is the summary data through January 29, 2022.

Total reactions for the mRNA vaccine Tozinameran (code BNT162b2,Comirnaty) from BioNTech/ Pfizer: 17,578 deaths and 1,704,757 injuries to 29/01/2022

48,240 Blood and lymphatic system disorders incl. 242 deaths
57,541 Cardiac disorders incl. 2,554 deaths
522 Congenital, familial and genetic disorders incl. 51 deaths
22,590 Ear and labyrinth disorders incl. 11 deaths
1,911 Endocrine disorders incl. 6 deaths
25,814 Eye disorders incl. 38 deaths
133,365 Gastrointestinal disorders incl. 681 deaths
422,360 General disorders and administration site conditions incl. 5,024 deaths
1,931 Hepatobiliary disorders incl. 90 deaths
18,455 Immune system disorders incl. 95 deaths
76,443 Infections and infestations incl. 1,878 deaths
33,972 Injury, poisoning and procedural complications incl. 331 deaths
42,585 Investigations incl. 502 deaths
11,344 Metabolism and nutrition disorders incl. 273 deaths
201,643 Musculoskeletal and connective tissue disorders incl. 212 deaths
1,629 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 153 deaths
278,744 Nervous system disorders incl. 1,859 deaths
2,513 Pregnancy, puerperium and perinatal conditions incl. 74 deaths
251 Product issues incl. 3 deaths
30,622 Psychiatric disorders incl. 207 deaths
6,150 Renal and urinary disorders incl. 266 deaths
68,129 Reproductive system and breast disorders incl. 6 deaths
72,531 Respiratory, thoracic and mediastinal disorders incl. 1,884 deaths
78,059 Skin and subcutaneous tissue disorders incl. 146 deaths
3,871 Social circumstances incl. 22 deaths
21,010 Surgical and medical procedures incl. 204 deaths
42,532 Vascular disorders incl. 766 deaths
Total reactions for the mRNA vaccine mRNA-1273 (CX-024414) from Moderna: 11,008 deaths and 543,543 injuries to 29/01/2022

12,365 Blood and lymphatic system disorders incl. 120 deaths
18,287 Cardiac disorders incl. 1,142 deaths
190 Congenital, familial and genetic disorders incl. 11 deaths
6,310 Ear and labyrinth disorders incl. 8 deaths
502 Endocrine disorders incl. 6 deaths
7,475 Eye disorders incl. 36 deaths
44,340 Gastrointestinal disorders incl. 413 deaths
145,153 General disorders and administration site conditions incl. 3,630 deaths
793 Hepatobiliary disorders incl. 54 deaths
5,370 Immune system disorders incl. 22 deaths
23,070 Infections and infestations incl. 1042 deaths
10,286 Injury, poisoning and procedural complications incl. 208 deaths
12,129 Investigations incl. 393 deaths
4,847 Metabolism and nutrition disorders incl. 263 deaths
66,358 Musculoskeletal and connective tissue disorders incl. 223 deaths
682 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 85 deaths
91,230 Nervous system disorders incl. 1,029 deaths
907 Pregnancy, puerperium and perinatal conditions incl. 10 deaths
98 Product issues incl. 4 deaths
9,441 Psychiatric disorders incl. 181 deaths
3,030 Renal and urinary disorders incl. 214 deaths
12,547 Reproductive system and breast disorders incl. 9 deaths
23,251 Respiratory, thoracic and mediastinal disorders incl. 1,162 deaths
27,540 Skin and subcutaneous tissue disorders incl. 96 deaths
2,239 Social circumstances incl. 45 deaths
3,028 Surgical and medical procedures incl. 203 deaths
12,075 Vascular disorders incl. 399 deaths
Total reactions for the vaccine AZD1222/VAXZEVRIA (CHADOX1 NCOV-19) from Oxford/ AstraZeneca: 7,977 deaths and 1,154,757 injuries to 29/01/2022

13,912 Blood and lymphatic system disorders incl. 278 deaths
20,984 Cardiac disorders incl. 830 deaths
235 Congenital familial and genetic disorders incl. 8 deaths
13,406 Ear and labyrinth disorders incl. 7 deaths
692 Endocrine disorders incl. 6 deaths
20,086 Eye disorders incl. 32 deaths
107,453 Gastrointestinal disorders incl. 434 deaths
304,993 General disorders and administration site conditions incl. 1,855 deaths
1,039 Hepatobiliary disorders incl. 69 deaths
5,409 Immune system disorders incl. 40 deaths
42,266 Infections and infestations incl. 620 deaths
13,630 Injury poisoning and procedural complications incl. 198 deaths
25,681 Investigations incl. 205 deaths
13,023 Metabolism and nutrition disorders incl. 126 deaths
168,174 Musculoskeletal and connective tissue disorders incl. 165 deaths
743 Neoplasms benign malignant and unspecified (incl cysts and polyps) incl. 40 deaths
234,117 Nervous system disorders incl. 1,178 deaths
635 Pregnancy puerperium and perinatal conditions incl. 20 deaths
199 Product issues incl. 1 death
21,051 Psychiatric disorders incl. 69 deaths
4,338 Renal and urinary disorders incl. 78 deaths
16,849 Reproductive system and breast disorders incl. 3 deaths
41,401 Respiratory thoracic and mediastinal disorders incl. 1,082 deaths
52,064 Skin and subcutaneous tissue disorders incl. 65 deaths
1,617 Social circumstances incl. 9 deaths
1,973 Surgical and medical procedures incl. 30 deaths
28,787 Vascular disorders incl. 529 deaths
Total reactions for the COVID-19 vaccine JANSSEN (AD26.COV2.S) from Johnson & Johnson: 2,420 deaths and 127,305 injuries to 29/01/2022

1,229 Blood and lymphatic system disorders incl. 51 deaths
2,552 Cardiac disorders incl. 204 deaths
40 Congenital, familial and genetic disorders incl. 1 death
1,319 Ear and labyrinth disorders incl. 3 deaths
105 Endocrine disorders incl. 1 death
1,656 Eye disorders incl. 10 deaths
9,588 Gastrointestinal disorders incl. 88 deaths
34,487 General disorders and administration site conditions incl. 685 deaths
153 Hepatobiliary disorders incl. 13 deaths
544 Immune system disorders incl. 10 deaths
8,521 Infections and infestations incl. 207 deaths
1,147 Injury, poisoning and procedural complications incl. 25 deaths
6,086 Investigations incl. 131 deaths
756 Metabolism and nutrition disorders incl. 60 deaths
17,116 Musculoskeletal and connective tissue disorders incl. 55 deaths
86 Neoplasms benign, malignant and unspecified (incl cysts and polyps) incl. 8 deaths
23,413 Nervous system disorders incl. 245 deaths
55 Pregnancy, puerperium and perinatal conditions incl. 1 death
30 Product issues
1,766 Psychiatric disorders incl. 22 deaths
535 Renal and urinary disorders incl. 31 deaths
2,941 Reproductive system and breast disorders incl. 6 deaths
4,468 Respiratory, thoracic and mediastinal disorders incl. 304 deaths
3,760 Skin and subcutaneous tissue disorders incl. 10 deaths
409 Social circumstances incl. 4 deaths
867 Surgical and medical procedures incl. 74 deaths
3,676 Vascular disorders incl. 171 deaths

https://healthimpactnews.com/2022/38983-death...itzerland/
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Singlewire's Alert Badge Wins Vision Award in 2026

Updated Category News Views 0

A Badge That Reshapes Communication Safety You might think a simple badge wouldn't earn much fanfare, but here we are — the InformaCast Wearable Alert Badge from Singlewire Software has snagged a prestigious spot at FacilitiesNet's 2026 Vision Awards. What makes this badge special? Well, it's not just a bauble to pin on your lapel; it's a deceptively simple yet powerful...

Continue Reading
Exploring Denture to Implant Solutions with Dr. Miller

Updated Category News Views 4

The Changing Face of Tooth Replacement Let's dive into teeth. We're talking dentures, implants, and the rest of the gang that live in the world of full mouth replacements. Dr. Christopher Glenn Miller’s insights shared with HelloNation zero in on the evolution of tooth replacement options. Gone are the days of clunky dentures being your only shot. From sucking gum to...

Continue Reading
Claroty Earns Top Marks in OT Security Evaluation

Updated Category News Views 7

A Closer Look at Claroty's Forrester Acclaim The waves of cybersecurity analysis have peeled back again, revealing a shining star—Claroty. The latest third-party evaluations seem to show that this beast of a company isn't just cruising; it's tearing up the operational technology security landscape. Named as both a 'Leader' and a 'Customer Favorite' in The Forrester...

Continue Reading
Olive Tree People Brings Waterless Beauty to the U.S.

Updated Category News Views 9

Olive Trees and Beauty: A New California Installment When you hear Olive Tree People, you might not instantly think of beauty products. Still, that's precisely what's making waves over on Abbot Kinney Boulevard in Venice, California. They've launched their first U.S. flagship, and it's not just about selling products—it's a downright spectacle of innovation. With 45,000...

Continue Reading
Jeen's Real-Time AI Cost Management Unveiled

Updated Category News Views 2

Unmasking the Ghosts in AI Expenses Enterprises are thrashing around in the digital ocean of AI, yet many still can't see what's draining their coffers. It's not just the savant data scientists racking up the charges; it's every automated agent chipping away at resources—unnoticed until the bill finally lands. That's where Jeen is stepping in, flipping the script on...

Continue Reading
Safety Tech in Fleets: Drivers Embrace Its Role

Updated Category News Views 5

Drivers Warming Up to Fleet Safety Tech Seems like most fleet drivers these days are eyeing safety tech through a fresher lens. Gone are the days when grumbling about privacy was the anthem of the disgruntled. The latest Linxup survey claims a whopping 77% of commercial fleet pros have hopped onto the safety train, happily trading privacy qualms for the perks of solid...

Continue Reading
Grants Strengthen Future Skills in Culinary Education

Updated Category News Views 3

Irons are heating up on the griddle of education as The Rachael Ray Foundation teams up with the National Restaurant Association Educational Foundation over a piping hot new initiative. They’re offering up $5,000 grants aimed squarely at bolstering high school culinary education. It's not every day you see such direct support for the next generation of culinary...

Continue Reading
Elbphilharmonie Hamburg: 10th Anniversary Marks Milestone

Updated Category News Views 2

Elbphilharmonie's Impact on Hamburg's Cultural Landscape Here we are, staring down the first decade of the Elbphilharmonie, and boy, if that isn't a testament to sticking your neck out for culture, I don't know what is. Opened back on January 11, 2017, this concert hall started as just another controversial project, folks wagging tongues about costs and ambition. But...

Continue Reading
Ignyte Insurance Acquires InsureMyTrip to Expand Portfolio

Updated Category News Views 1

Key Acquisition: Strengthening Global Presence Ignyte Insurance just added a major player to its roster with the acquisition of InsureMyTrip. No two ways about it, this move is about expanding their footprint in the booming travel and medical insurance sector. Now, if you've ever thought travel insurance was just fine print nobody reads, think again. This industry’s got...

Continue Reading
Early Education's Massive Impact: Key Skills for Success

Updated Category News Views 1

Unlocking Lifelong Success: The Early Advantage Ever look at a successful adult and wonder, "Where'd they get that spark?" According to HelloNation and child care expert Karen Ego, it all starts early. Think of early learning not just as prepping for school, but as the first blueprint for life's journey. It's the skills you pick up in those tender years that stick it out...

Continue Reading

Top 5 Most Recently Viewed Articles

Exciting Announcement of Global Phygital Stars for 2025 Games

Updated Category News Views 131

Global Phygital Stars Set to Compete in 2025 Games Phygital International is thrilled to reveal the first round of elite clubs participating in the highly anticipated Games of the Future 2025. Set to take place in Abu Dhabi, this groundbreaking event is poised to revolutionize the world of sports with a blend of physical prowess and advanced digital gameplay. A Fusion of...

Continue Reading
AtData Celebrates 2025 Sammy Award for Email Marketing Innovation

Updated Category News Views 101

AtData Wins 2025 Sammy Award in Sales and Marketing Technology Email address intelligence provider recognized for its innovative approach to merging identity with marketing and fraud prevention. Celebrating Innovation in Email Intelligence AtData, a prominent innovator in email address intelligence and data security solutions, has been named a winner in the 2025 Sammy –...

Continue Reading
Hungry Howie's Achieves Remarkable Growth and Flavor Innovations

Updated Category News Views 139

Hungry Howie's Caps Off a Year of Growth and Innovation Hungry Howie's, the well-known pizza franchise famous for its Flavored Crust® pizza, is celebrating an impactful year marked by innovative menu changes, strategic expansions, and enhanced community engagement. As the competitive restaurant landscape continues to evolve, Hungry Howie's made strong strides in...

Continue Reading
Revolutionizing Cardiology: Philips' Latest Innovations Enhanced

Updated Category News Views 277

Philips Transforms Cardiology with Cutting-Edge Innovations At the upcoming TCT annual meeting, Philips is set to unveil its latest advancements in the field of cardiology. This exhibition, scheduled for a later date, will showcase a portfolio of image-guided therapy and echocardiography solutions that seamlessly integrate artificial intelligence into their imaging...

Continue Reading
Colliers' Recent Financial Growth and Strategic Adjustments

Updated Category News Views 131

Strong Financial Performance in the First Quarter Colliers International Group Inc. (NASDAQ and TSX: CIGI) has showcased remarkable financial performance, reflecting significant operational achievements in the latest quarter. The company's consolidated revenues soared to $1.14 billion, marking a notable increase of 14% year-over-year. This growth demonstrates the...

Continue Reading